Nestlé has signalled its intention to become a force in consumer healthcare by acquiring Canadian supplements specialist Atrium Innovations for US$2.3 billion (€1.95 billion) from a group of investors led by Permira Funds. Subject to regulatory approval, the transaction is expected to close in the first quarter of 2018.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?